Pricing Log in Create free account
Friday 6 November 2026 Export ENSG’s income statement to Excel — free account

The Ensign Group, Inc.

ENSG Healthcare Medical Care Facilities

The Ensign Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $5.1 billion, up 18.7% from fiscal 2024.

Revenue
+14.5%
EPS
+23.6%
Free cash flow
+89.2%
Total debt
+39.2%

Quarter to September 2026, against a year earlier

181.95 6.36 −3.38%
Market cap
$10.6B
P/E
26.3×
Fwd P/E
25.4×
Dividend yield
0.14%
F-score
7/9
Altman Z
3.57
Beneish M
−2.57
Dividend safety
92/100
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

The Ensign Group, Inc. (ENSG) EV/EBITDA

Alert me on EV/EBITDA

As of 5 November 2026, The Ensign Group, Inc. (ENSG) trades at a EV/EBITDA of 16.4×. Over the past ten years it has ranged from 7.6× (February 2016) to 25.6× (July 2019); the current reading is higher than 65% of that period. That is above the Medical Care Facilities industry median of 11.9× and above the Healthcare sector median of 8.4×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 18.0× 11.71%
FY2024 16.1× (11.84%)
FY2023 18.3× 31.43%
FY2022 13.9× (0.97%)
FY2021 14.0× 3.97%
FY2020 13.5× (8.50%)
FY2019 14.8× (7.33%)
FY2018 15.9× 0.89%
FY2017 15.8× 64.05%
FY2016 9.6× 4.50%

Quarterly newest first

Period EV/EBITDA Change
Sep 2026 15.5× (1.07%)
Jun 2026 15.6× (21.95%)
Mar 2026 20.0× 11.22%
Dec 2025 18.0× (5.30%)
43 more quarters

Against its own ten years

Low 7.6× High 25.6×
Ten-year median 14.5×
Current reading's percentile 65

EV/EBITDA against peers

Company EV/EBITDA
FMS Fresenius Medical Care AG & Co. KGaA compare 5.1×
UHS Universal Health Services, Inc. compare 6.4×
DVA DaVita Inc. compare 8.0×
EHC Encompass Health Corporation compare 10.7×
CON Concentra Group Holdings Parent, Inc. compare 14.0×
PACS PACS Group, Inc. compare 16.2×
CHE Chemed Corporation compare 16.3×
ENSG The Ensign Group, Inc. 16.4×
LFST LifeStance Health Group, Inc. compare 32.0×
Medical Care Facilities industry median 11.9×
Healthcare sector median 8.4×
Market median 10.9×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on ENSG